Two blood-thinner schedules for clot prevention in very obese surgery patients
Part of Hormones & metabolism clinical trials.
This study compares two different schedules of bemiparin (a blood thinner) to prevent dangerous blood clots after surgery in people with very high body weight. It may help find the safest and most effective dose/timing for clot prevention around the time of surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are scheduled for surgery in general surgery, gynecology, or bariatric (weight-loss) surgery
- Your clot risk is rated moderate to very high (using the Caprini risk system)
- Your BMI is 40 or higher
- You can understand the study and sign informed consent
- You must be able to follow the study plan and return for follow-up visits
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two blood-thinning medications, rivaroxaban (a pill) and enoxaparin (a shot), to prevent dangerous blood clots after weight-loss surgery. If you are scheduled for bariatric surgery, this trial could help determine which approach works better for someone like you.
This trial tests whether a blood-thinner medication (tinzaparin) can safely prevent dangerous blood clots in people with obesity who are having weight-loss surgery. The study happens at St Vincent's University Hospital in Dublin, Ireland.
This trial studies the best way to manage blood thinning (anticoagulation) during heart surgery that uses a heart-lung machine in people with obesity. It may help reduce blood-clotting and bleeding complications by comparing different care strategies.
This study compares giving enoxaparin (a blood thinner) in two different spots on the body (belly vs. thigh) for patients with severe obesity who need to prevent blood clots after surgery or hospital stay. The goal is to see which injection site works best.
This trial compares different blood clot prevention strategies for people over 18 with colorectal cancer who are having surgery lasting at least 45 minutes. It aims to find the best way to reduce the risk of dangerous blood clots after surgery.
This trial compares two blood thinners, Rivaroxaban (a pill) and Enoxaparin (a shot), to see which works better at preventing dangerous blood clots in the legs after emergency abdominal surgery. It may help you if you need to stay in bed for more than a day after your operation.
Hear when a new Morbid Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.